Human genetics and real‐world patient data fuel target and drug discovery in Alzheimer's disease using Artificial Intelligence

Abstract

Background: Although high‐throughput DNA/RNA sequencing technologies from the NIA‐funded Alzheimer's disease sequencing project (ADSP) have generated massive genetic and genomic data in human disease, translation of these findings into new patient treatment has not materialized by lack of effective approaches, such as

The paper